European guidelines on the management of arterial hypertension Guideline 10 February 2013 Pages: 2 - 2
Celecoxib, rofecoxib use often inappropriate in Australia Clinical study 10 February 2013 Pages: 3 - 3
CYP2D6 metabolism determines drug use in psychiatric disorders Clinical study 10 February 2013 Pages: 4 - 4
Nonprescription, herbal product use for CVD common in Canada Clinical study 10 February 2013 Pages: 4 - 4
Portable echocardiography saves time, costs in cardiac evaluation Clinical study 10 February 2013 Pages: 4 - 4
Ethnic disparities in osteoporosis therapy use in the US Clinical study 10 February 2013 Pages: 5 - 5
Folinic acid adjunctive therapy cost effective in colorectal cancer Clinical study 10 February 2013 Pages: 5 - 5
Antihypertensive prescribing improved with academic detailing Clinical study 10 February 2013 Pages: 6 - 6
Costs vary by urinary continence status in subacute care Clinical study 10 February 2013 Pages: 6 - 6
HIT warranted for schizophrenic hallucinations in The Netherlands? Clinical study 10 February 2013 Pages: 6 - 6
Age, ethnicity affect antipsychotic dosage in schizophrenia Clinical study 10 February 2013 Pages: 7 - 7
Multidisciplinary care cost beneficial for HF in Ireland Clinical study 10 February 2013 Pages: 7 - 7
Physicians regularly prescribe generic over brandname drugs Media release 10 February 2013 Pages: 7 - 7
Prophylactic antiarrhythmic therapies reduce AF, LOS, costs Clinical study 10 February 2013 Pages: 8 - 8
Enoxaparin dominates UFH for acute coronary syndromes in Poland Clinical study 10 February 2013 Pages: 9 - 9
Postnatal LOS increased following US state legislation Clinical study 10 February 2013 Pages: 10 - 10
Minimum price difference for parallel imports in Germany? Clinical study 10 February 2013 Pages: 12 - 12